FNDC5/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanisms
Cardiotoxicity remains a major limiting factor in the clinical implementation of anthracycline chemotherapy. Though the etiology of doxorubicin-dependent heart damage has yet to be fully elucidated, the ability of doxorubicin to damage DNA and trigger oxidative stress have been heavily implicated in...
Saved in:
Main Authors: | Manish Kumar, Abhishek Singh Sengar, Anushree Lye, Pranesh Kumar, Sukhes Mukherjee, Dinesh Kumar, Priyadip Das, Suvro Chatterjee, Adele Stewart, Biswanath Maity |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Redox Biology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231725000400 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression Analysis of Fibronectin Type III Domain-Containing (FNDC) Genes in Inflammatory Bowel Disease and Colorectal Cancer
by: Tilo Wuensch, et al.
Published: (2019-01-01) -
Anti-SARS-CoV-2 Biotherapeutics and Chemotherapeutics: An Insight into Product Specifications and Marketing Dynamics
by: Vijay Kotra, et al.
Published: (2022-12-01) -
Comparison of Cantharidin Toxicity in Breast Cancer Cells to Two Common Chemotherapeutics
by: Katie M. Kern, et al.
Published: (2014-01-01) -
Modification of Interleukin-15 Serum Levels in Workers Exposed to Chemotherapeutic Agents
by: Giovanna Spatari, et al.
Published: (2005-01-01) -
Evaluation of the basophil activation in immediate type
hypersensitivity reactions to chemotherapeutic agents
by: Gözde Köycü Buhari, et al.
Published: (2024-02-01)